Overall rank by patents
#47,488
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 0 technology areas, active 2023–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search.
The verdict
Heimiao holds 5 US patents across 0 technology areas, rank #47,488 of 50,000 tracked assignees.
Heimiao Technology (shenzhen) Co., Ltd. has been granted 5 US utility patents between 2023 and 2024, placing Heimiao Technology (shenzhen) Co., Ltd. at rank #47,488 across all assignees tracked by PlainPatent. This portfolio spans 0 distinct Cooperative Patent Classification (CPC) subclasses, averaging 1.0 claims per patent. As a Foreign Corporation, Heimiao Technology (shenzhen) Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Heimiao sits between Hefei Lifeon Pharmaceutical Co., Ltd. (5 patents, rank #47,484) and Hemovent Gmbh (5 patents, rank #47,492) - the closest US assignees by grant volume. The composite Innovation Score of 26.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2024, with 5 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Heimiao Technology (shenzhen) Co., Ltd.'s 1.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 0 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Heimiao Technology (shenzhen) Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Hefei Lifeon Pharmaceutical Co., Ltd.
5 patents
Heff Industries Inc.
5 patents
Heidelberg Engineering GmbH
5 patents
Heilux, LLC
5 patents
Helicoid Industries, Inc.
5 patents
Helinox Inc.
5 patents
Hemispheres for All, LLC
5 patents
Hemovent GmbH
5 patents
Heimiao Technology (Shenzhen) Co., Ltd.
5 patents
What this shows Heimiao holds 5 patents at rank #47,488, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #47,488 in granted patent volume.
Heimiao's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
27 Top 79% higher than 21% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 3 | 60.0% |
| 2024 | 2 | 40.0% |
Overall rank by patents
#47,488
Across all tracked assignees
26.8 out of 100
How to use this portfolio
Heimiao's 5 grants land it in the top 79% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.